Adicet Bio ACET
NASDAQ ACET
$9.36 -0.18 (-1.89%)
As of: Sep 10, 2026 · 2:03 PM EDT

Adicet Bio (ACET) Other Operating Expenses (2023)

Adicet Bio (ACET) posted Other Operating Expenses of $19.5 million for Q3 2023.

Analysis

Adicet Bio (ACET) Other Operating Expenses (2023) Analysis & Trends

Adicet Bio has reported Other Operating Expenses for 1 years, with the latest figure at $19.5 million in Q3 2023.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $19.5 million in Q3 2023; TTM through Jun 2024 was $19.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $466000.0, up 110.86% from the prior year.
  • Other Operating Expenses was $19.5 million for Q3 2023 at Adicet Bio.
  • The five-year high for Other Operating Expenses was $19.5 million in Q3 2023, with the low at $19.5 million in Q3 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.21 Bn 9.36 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.03 Bn 5.03 Bn -
3 Iovance Biotherapeutics 3.64 Bn 3.35 Bn 55.72 Mn
4 Legend Biotech 3.54 Bn 2.57 Bn 251.50 Mn
5 uniQure 2.98 Bn 2.98 Bn 5.49 Mn
6 Beam Therapeutics 2.52 Bn 2.52 Bn -
7 Precigen 2.38 Bn 2.38 Bn 52.17 Mn
8 Sarepta Therapeutics 2.14 Bn 1.35 Bn 251.87 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn
10 Adicet Bio 100.58 Mn -17.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2023 19.46 Mn